Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 percent of the U.S. has taken one of these drugs and 6 percent are currently taking them.

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart disease and sleep apnea—and the U.

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover weight loss drugs.

Ozempic may help reduce alcohol cravings, according to a new study. But you shouldn't use them to help curb drinking habits just yet.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.